Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | -1.74% | 77.54 | 5.6% | $201.44m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -2.01% | 25.88 | 14.1% | $152.28m | |
| CTLT | Catalent, Inc. | -0.97% | 114.12 | 2.1% | $112.56m | |
| BHC | Bausch Health Cos., Inc. | -2.01% | 25.88 | 0.0% | $89.11m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.40% | 166.48 | 2.4% | $87.69m | |
| UTHR | United Therapeutics Corp. | 1.67% | 170.05 | 14.1% | $65.84m | |
| SAGE | SAGE Therapeutics, Inc. | -4.66% | 92.25 | 7.6% | $55.57m | |
| ACST | Acasti Pharma, Inc. | -4.93% | 0.60 | 0.2% | $50.04m | |
| GWPH | GW Pharmaceuticals Plc | 0.23% | 138.15 | 6.1% | $48.51m | |
| AMRN | Amarin Corp. Plc | -0.33% | 6.11 | 1.5% | $47.34m | |
| PRGO | Perrigo Co. Plc | -0.63% | 44.37 | 6.8% | $47.04m | |
| ISR | IsoRay, Inc. | 4.62% | 2.00 | 2.5% | $45.53m | |
| ICLR | ICON plc | -0.47% | 209.68 | 4.2% | $42.69m | |
| ENDP | Endo International Plc | -0.62% | 7.18 | 8.7% | $37.84m | |
| ARGX | argenx SE | 0.04% | 282.29 | 0.0% | $37.79m |
Company Profile
Synergy Pharmaceuticals Inc., headquartered in New York, NY with laboratories in Doylestown, PA, is a biopharmaceutical company focused on the research and development of novel therapies for the treatment of chronic idiopathic constipation, irritable bowel syndrome with constipation and other difficult-to-treat gastrointestinal (GI) conditions. Synergy’s lead drug, plecanatide, and next-generation candidate, SP-333, are proprietary analogs of the natural human GI hormone, uroguanylin, and members of the new class of guanylate cyclase-C (“GC-Câ€) agonists.